Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera was incorporated on June 4, 2003 under the laws of the State of Delaware. Alimera Sciences, Inc. (ALIM) Stock Analysis & News ... Get breaking news and analysis on Alimera Sciences, Inc. (ALIM) stock, price quote and chart, trading and investing tools. Alimera Sciences, Inc. (ALIM) Stock Forum & Discussion ... Find the latest Alimera Sciences, Inc. (ALIM) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Alimera Sciences, Inc. (NASDAQ: ALIM) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and
Find real-time ALIM - Alimera Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. ALIM Alimera Sciences, Inc. — Stock Price and Discussion ... Real-time trade and investing ideas on Alimera Sciences, Inc. ALIM from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. ALIM: Alimera Sciences Inc - Stock Price, Quote and News ... Get Alimera Sciences Inc (ALIM:NASDAQ) real-time stock quotes, news and financial information from CNBC. Alimera Sciences Inc Stock Quote: ALIM Stock News, Quotes ...
Alimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates through U.S. and International segment. The Company focuses on diseases affecting the back of the
Alimera Sciences Inc. ALIM - Quotes, Financials, News ... Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. Safe(er) Stock in category See
Alimera Sciences, Inc. (ALIM) Stock Forum & Discussion ...
Alimera Sciences, Inc. (ALIM) stock price, quote, history ... Alimera Sciences (ALIM) Tops Q4 Earnings and Revenue Estimates. Alimera Sciences (ALIM) delivered earnings and revenue surprises of 121.62% and 19.64%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock? Alimera Sciences Inc (ALIM) Quote | Morningstar
Alimera is a risky penny stock with upside potential, provided management continues reporting quarterly revenue growth. For now, then, Alimera stock looks like a buy.
Alimera Sciences Announces Effectiveness of Previously ... Mar 05, 2020 · Alimera Sciences Announces Effectiveness of Previously Announced Reverse Stock Split ATLANTA, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a … Alimera Sciences, Inc. (ALIM) Stock: Why It’s Headed Down ...
ALIM: Get the latest Alimera Sciences stock price and detailed information including ALIM news, historical charts and realtime prices. Alimera Sciences, Inc. engages in the research and Alimera Sciences - Wikipedia